During the past decade, Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia; Oncologia Medica conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 11 clinical trials were completed, i.e. on average, 68.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia; Oncologia Medica" #1 sponsor was "Hoffmann-La Roche" with 18 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "Fondazione Ricerca Traslazionale" with 2 trials sponsored, "Gruppo Oncologico del Nord-Ovest" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia; Oncologia Medica" #1 collaborator was "AOU S.Orsola Malpighi-Unit of Oncologic Molecular and Transplantations Pathology" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "AOU S. Orsola Malpighi - Clinical Trial Office" with 1 trials as a collaborator, "Bioikos Ambiente Srl" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia; Oncologia Medica" are "Breast Cancer" (5 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials), "Leukemia" (3 trials), "Non-Small Cell Lung Cancer" (3 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia; Oncologia Medica" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia; Oncologia Medica" are "Drug" (31 trials), "Biological" (1 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alectinib" (4 trials), "Carboplatin" (4 trials), "Docetaxel" (4 trials), "Placebo" (4 trials) and "Atezolizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia; Oncologia Medica" are 31 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia; Oncologia Medica". undefined are not yet recruiting, 4 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia; Oncologia Medica, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia; Oncologia Medica, 3 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".